Chemours Co Retains 'Hold' Rating with $25 Price Target

Chemours Co maintains a 'Hold' rating from analysts, with a top price target of $25 implying 45% upside potential. The company demonstrates stable fundamentals and high institutional ownership despite recent market fluctuations.